These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29749876)

  • 1. CD4 cell count variability with repeat testing in South Africa: Should reporting include both absolute counts and ranges of plausible values?
    Daniel Francois Venter W; Chersich MF; Majam M; Akpomiemie G; Arulappan N; Moorhouse M; Mashabane N; Glencross DK
    Int J STD AIDS; 2018 Nov; 29(11):1048-1056. PubMed ID: 29749876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near patient CD4 count in a hospitalized HIV patient population.
    Givens M; Weaver A; Bickman S; Logan C; Noormahomed EV; Patel S; Schooley RT; Benson CA; Lochhead MJ
    Cytometry B Clin Cytom; 2017 Nov; 92(6):451-455. PubMed ID: 25917935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4 results with a bias larger than hundred cells per microliter can have a significant impact on the clinical decision during treatment initiation of HIV patients.
    Daneau G; Buyze J; Wade D; Diaw PA; Dieye TN; Sopheak T; Florence E; Lynen L; Kestens L
    Cytometry B Clin Cytom; 2017 Nov; 92(6):476-484. PubMed ID: 26917223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of point-of-care CD4 cell count results on linkage to care and antiretroviral initiation during a home-based HIV testing campaign: a non-blinded, cluster-randomised trial.
    Desai MA; Okal DO; Rose CE; Ndivo R; Oyaro B; Otieno FO; Williams T; Chen RT; Zeh C; Samandari T
    Lancet HIV; 2017 Sep; 4(9):e393-e401. PubMed ID: 28579225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of point-of-care versus laboratory-based CD4 cell enumeration in HIV-positive pregnant women.
    Myer L; Daskilewicz K; McIntyre J; Bekker LG
    J Int AIDS Soc; 2013 Sep; 16(1):18649. PubMed ID: 24044627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Criteria for initiating highly active antiretroviral therapy and short-term immune response among HIV-1-infected patients in Côte d'Ivoire.
    Diabaté S; Alary M
    HIV Med; 2009 Nov; 10(10):640-6. PubMed ID: 19659945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa.
    Lawn SD; Myer L; Bekker LG; Wood R
    BMC Infect Dis; 2006 Mar; 6():59. PubMed ID: 16551345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in CD4+ T-Cell Count at the Time of HIV Diagnosis and Antiretroviral Treatment Initiation Among Persons With HIV in New York City.
    Braunstein SL; Robertson MM; Myers J; Abraham B; Nash D
    J Infect Dis; 2016 Dec; 214(11):1682-1686. PubMed ID: 27892400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
    Boyer S; Iwuji C; Gosset A; Protopopescu C; Okesola N; Plazy M; Spire B; Orne-Gliemann J; McGrath N; Pillay D; Dabis F; Larmarange J;
    AIDS Care; 2016; 28 Suppl 3(Suppl 3):39-51. PubMed ID: 27421051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
    Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
    Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
    Hecht FM; Wang L; Collier A; Little S; Markowitz M; Margolick J; Kilby JM; Daar E; Conway B; Holte S;
    J Infect Dis; 2006 Sep; 194(6):725-33. PubMed ID: 16941337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ T-lymphocytes cell counts in adults with human immunodeficiency virus infection at the medical department of a tertiary health institution in Nigeria.
    Ajayi AO; Ajayi EA; Fasakin KA
    Ann Afr Med; 2009; 8(4):257-60. PubMed ID: 20139549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
    Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
    Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory-based performance evaluation of PIMA CD4+ T-lymphocyte count point-of-care by lay-counselors in Kenya.
    Zeh C; Rose CE; Inzaule S; Desai MA; Otieno F; Humwa F; Akoth B; Omolo P; Chen RT; Kebede Y; Samandari T
    J Immunol Methods; 2017 Sep; 448():44-50. PubMed ID: 28529048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy.
    Huttner AC; Kaufmann GR; Battegay M; Weber R; Opravil M
    AIDS; 2007 May; 21(8):939-46. PubMed ID: 17457087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Factors Related to CD4+ T-Cell Recovery and Viral Suppression in Patients Who Have Low CD4+ T Cell Counts at the Initiation of HAART: A Retrospective Study of the National HIV Treatment Sub-Database of Zhejiang Province, China, 2014.
    He L; Pan X; Dou Z; Huang P; Zhou X; Peng Z; Zheng J; Zhang J; Yang J; Xu Y; Jiang J; Chen L; Jiang J; Wang N
    PLoS One; 2016; 11(2):e0148915. PubMed ID: 26900702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
    Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
    Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations.
    Williams BG; Korenromp EL; Gouws E; Schmid GP; Auvert B; Dye C
    J Infect Dis; 2006 Nov; 194(10):1450-8. PubMed ID: 17054076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.